CCS
QGENF

Crosspoint Capital Strategies’s QIAGEN NV QGENF Stock Holding History

Crosspoint Capital Strategies’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-570
Closed -$14K – 993
2015
Q2 		$14K Sell
570
-17
-3% -$418 ﹤0.01% 462
2015
Q1 		$15K Buy
+587
New +$15K 0.01% 373

Other funds holding QGENF

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM

Crosspoint Capital Strategies's QGENF Position: Q3 2015 in Review

Crosspoint Capital Strategies sold out of QIAGEN NV (QGENF) in Q3 2015, closing a stake of 570 shares — an estimated $14K sold.

Crosspoint Capital Strategies first reported a position in QGENF in Q1 2015 and held it in 2 quarters. The position peaked at $15K in Q1 2015. 190 funds tracked by Wall St. Rank hold QGENF as of Q3 2015.

  • Crosspoint Capital Strategies reported no remaining QIAGEN NV position as of Q3 2015 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 570 QIAGEN NV shares in Q3 2015, an estimated $14K.
  • Crosspoint Capital Strategies first reported a position in QIAGEN NV in Q1 2015 and held it in 2 quarters.
  • Crosspoint Capital Strategies's QIAGEN NV position peaked at $15K in Q1 2015.
  • 190 funds tracked by Wall St. Rank held QIAGEN NV as of Q3 2015.

Based on Crosspoint Capital Strategies's 13F filing for Q3 2015, filed 25 Nov 2015.